Heparin-appended polycaprolactone core/corona nanoparticles for site specific delivery of 5-fluorouracil

被引：7
|
作者：
Garg, Ashish [1 ]
Patel, Vaibhav [1 ]
Sharma, Rajeev [2 ]
Jain, Amit [3 ]
Yadav, Awesh K. [3 ]
机构：
[1] Guru Ramdas Khalsa Inst Sci & Technol, Drug Delivery & Nanotechnol Labs, Dept Pharmaceut, Pharm, Jabalpur, India
[2] Dr HS Gour Vishwavidyalaya, Dept Pharmaceut Sci, Drug Delivery Res Lab, Sagar, Madhya Pradesh, India
[3] Bhagyoday Tirth Pharm Coll, Dept Pharmaceut, Nanotechnol Project Labs, Sagar, Madhya Pradesh, India
来源：
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY | 2017年 / 45卷 / 06期
关键词：
Cellular cytotoxicity; 5-fluorouracil; heparin; nanoparticles; polycaprolactone; CHOLESTEROL-RICH NANOEMULSION; DRUG-DELIVERY; SIZE DISTRIBUTION; CELLS; LDE;
D O I：
10.1080/21691401.2016.1203793
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
The aim of the present work is to formulate heparin-modified-polycaprolactone (HEP) core shell nanoparticles (NPs) of 5-fluorouracil (5-FU). These NPs were characterized for various in vitro parameters like particle size, zeta potential, etc. HEP NPs were found to maintain comparatively slower drug release pattern (98.9% in 96h) than PCL NPs. Cytotoxicity studies demonstrated a massive cytotoxic potential of 5-FU-loaded HEP NPs in A549, MDA-MD-435, and SK-OV-3 cancer cell lines. Pharmacokinetic parameters were also determined in blood after IV administration of HEP NPs: AUC, C-max, MRT, and T-max values are 6096.075 +/- 5.90gh/mL, 144.38 +/- 1.52g/L, 58.71 +/- 0.25h, 96 +/- 0.50h, respectively and 117.92 +/- 1.78, 45.35 +/- 3.00, 1.2 +/- 0.25, 0.5 +/- 0.02 in plain 5-FU solution.
引用
收藏
页码：1146 / 1155
页数：10
相关论文
共 50 条
  • [1] Polycaprolactone–Gelatin Membranes in Controlled Drug Delivery of 5-Fluorouracil
    Dariush Faezeh Ghahreman
    Saied Nouri Semnani
    Jaleh Khorasani
    Shahla Varshosaz
    Sajjad Khalili
    Elham Mohammadi
    Polymer Science, Series A, 2020, 62 : 636 - 647
  • [2] Polycaprolactone-Gelatin Membranes in Controlled Drug Delivery of 5-Fluorouracil
    Ghahreman, Faezeh
    Semnani, Dariush
    Khorasani, Saied Nouri
    Varshosaz, Jaleh
    Khalili, Shahla
    Mohammadi, Sajjad
    Kaviannasab, Elham
    POLYMER SCIENCE SERIES A, 2020, 62 (06) : 636 - 647
  • [3] Heparin appended ADH-anionic polysaccharide nanoparticles for site-specific delivery of usnic acid
    Garg, Ashish
    Garg, Sweta
    Sahu, Nitendra K.
    Rani, Sarita
    Gupta, Umesh
    Yadav, Awesh K.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2019, 557 : 238 - 253
  • [4] In vitro release and cytotoxicity activity of 5-fluorouracil entrapped polycaprolactone nanoparticles
    Moshera Samy
    Heba M. Abdallah
    Hanem M. Awad
    Magdy M. H. Ayoub
    Polymer Bulletin, 2022, 79 : 6645 - 6671
  • [5] In vitro release and cytotoxicity activity of 5-fluorouracil entrapped polycaprolactone nanoparticles
    Samy, Moshera
    Abdallah, Heba M.
    Awad, Hanem M.
    Ayoub, Magdy M. H.
    POLYMER BULLETIN, 2022, 79 (08) : 6645 - 6671
  • [6] Eco-friendly Route for Encapsulation of 5-Fluorouracil into Polycaprolactone Nanoparticles
    Samy, Moshera
    Abdallah, Heba M.
    Ayoub, Magdy M. H.
    Vylegzhanina, M. E.
    Volkov, A. Ya
    Sukhanova, T. E.
    EGYPTIAN JOURNAL OF CHEMISTRY, 2020, 63 (01): : 255 - 267
  • [7] Matrices for site-specific controlled-delivery of 5-fluorouracil to descending colon
    Zambito, Y
    Baggiani, A
    Carelli, V
    Serafini, MF
    Di Colo, G
    JOURNAL OF CONTROLLED RELEASE, 2005, 102 (03) : 669 - 677
  • [8] Poly(butylcyanoacrylate) nanoparticles for topical delivery of 5-fluorouracil
    Simeonova, M
    Velichkova, R
    Ivanova, G
    Enchev, V
    Abrahams, I
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 263 (1-2) : 133 - 140
  • [9] Magnetite/poly(alkylcyanoacrylate) (core/shell) nanoparticles as 5-Fluorouracil delivery systems for active targeting
    Arias, Jose L.
    Gallardo, Visitacion
    Adolfina Ruiz, M.
    Delgado, Angel V.
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2008, 69 (01) : 54 - 63
  • [10] Intracellularly biorecognizable derivatives of 5-fluorouracil - Implications for site-specific delivery in the human condition
    Putnam, DA
    Shiah, JG
    Kopecek, J
    BIOCHEMICAL PHARMACOLOGY, 1996, 52 (06) : 957 - 962
12345